Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | 922,40 € | 1.080,6 € | 17,15 % |
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | 807,70 € | 832,87 € | 3,12 % |
| arGEN X BV | 1 | 0 | 0 | 0 | 484,20 € | 470,00 € | -2,93 % |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 1 | 0 | 414,75 € | 440,14 € | 6,12 % |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | 312,60 € | 408,19 € | 30,58 % |
| United Therapeutics | 29 | 1 | 2 | 0 | 324,20 € | 341,89 € | 5,46 % |
| Icon plc | 27 | 0 | 5 | 0 | 267,30 € | 327,46 € | 22,51 % |
| Amgen Inc. | 29 | 1 | 3 | 1 | 291,20 € | 304,82 € | 4,68 % |
| Alnylam Pharmace. | 44 | 0 | 1 | 0 | 244,10 € | 275,25 € | 12,76 % |
| BeiGene Ltd ADR | 8 | 1 | 0 | 0 | 224,00 € | 263,72 € | 17,73 % |
| UCB S.A. | 1 | 0 | 1 | 0 | 166,55 € | 210,00 € | 26,09 % |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | 173,08 € | 196,17 € | 13,34 % |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | 185,00 € | 195,00 € | 5,41 % |
| Johnson & Johnson | 41 | 1 | 6 | 0 | 146,04 € | 192,63 € | 31,90 % |
| Krystal Biotech | 19 | 0 | 1 | 0 | 161,40 € | 184,02 € | 14,01 % |
| Repligen Corp. | 15 | 0 | 1 | 0 | 131,60 € | 183,52 € | 39,45 % |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | 99,66 € | 182,69 € | 83,31 % |
| AbbVie Inc. | 33 | 0 | 0 | 0 | 176,98 € | 181,45 € | 2,52 % |
| Merck KGaA | 8 | 1 | 4 | 0 | 155,30 € | 172,00 € | 10,75 % |
| AstraZeneca plc | 2 | 0 | 0 | 0 | 141,00 € | 165,00 € | 17,02 % |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 130,00 € | 150,00 € | 15,38 % |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | 105,00 € | 144,48 € | 37,60 % |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | 100,00 € | 126,38 € | 26,38 % |
| Abbott Laboratories | 22 | 0 | 3 | 0 | 102,60 € | 116,48 € | 13,53 % |
| Novartis AG ADR | 4 | 0 | 1 | 0 | 104,00 € | 112,40 € | 8,07 % |